Linda Janisch

Genetic Variants in the <i>UDP-glucuronosyltransferase 1A1</i> Gene Predict the Risk of Severe Neutropenia of Irinotecan

Federico Innocenti, Samir D. Undevia, Lalitha Iyer et al. · Journal of Clinical Oncology · 2004 · 954 citations · Full text

Medicine, Oncology, Pharmacology +17

UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity

Lalitha Iyer, Soma Das, Linda Janisch et al. · The Pharmacogenomics Journal · 2002 · 712 citations

Pharmacy, Pharmacokinetics, Pharmacology +9

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors

Jason J. Luke, Jeffrey M. Lemons, Theodore Karrison et al. · Journal of Clinical Oncology · 2018 · 587 citations

Medicine, Oncology, Radiation Oncology +17

Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer

Razelle Kurzrock, Steven I. Sherman, Douglas W. Ball et al. · Journal of Clinical Oncology · 2011 · 551 citations · Full text

Medicine, Oncology, Pharmacology +17

Pharmacogenomic and Pharmacokinetic Determinants of Erlotinib Toxicity

Charles M. Rudin, Wanqing Liu, Apurva A. Desai et al. · Journal of Clinical Oncology · 2008 · 219 citations · Full text

Medicine, Oncology, Pharmacology +15